Printer Friendly

First Annual Conference on New Field of Regenerative Medicine to Be Held December 3-5 in Washington, D.C.

Business Editors & Health/Medical Writers

LARCHMONT, N.Y.--(BW HealthWire)--Oct. 23, 2000

The First Annual Conference on Regenerative Medicine, "Regenerative Medicine: A Unique Approach to Healing," presented by Mary Ann Liebert, Inc., Publishers, will be held at the Renaissance Hotel in Washington, D.C., on December 3-5, 2000.

This groundbreaking event is jointly sponsored by the University of South Florida College of Medicine and e-biomed: The Journal of Regenerative Medicine, a Mary Ann Liebert peer-reviewed electronic journal founded and edited by William Haseltine, Ph.D., who will chair the symposium.

The conference is the first to focus on this new area of scientific investigation, which represents a unique approach to healing by using the body's own stem cells, genes, proteins, and growth factors to repair organs, tissues, and cells. It will bring together leading researchers, scientists, physicians, and entrepre-neurs in cell biology, gene therapy, and tissue engineering to share the latest advances in biocompatible materials, bioinformatics, cell and stem cell biology, cloning, embryology, genomics, organogenesis, and transplantation biology and medicine.

Conference chairman William A. Haseltine, Ph.D., chairman and CEO of Human Genome Sciences (HGS), Inc., Rockville, Maryland, who coined the term regenerative medicine, will deliver the keynote address on tissue regeneration. "The implications of renewing body tissues with the help of natural signals that control its growth are far-reaching for the field of medicine," he said. "Regenerative medicine embraces concepts such as the construction of functional organs outside the body for implantation, stem cell biology to augment and replace damaged or worn tissues and organs, and electromechanical prostheses to supplement body functions that have been irreversibly damaged and that are not amenable to transplant."

Conference sessions and speakers are as follows: "Tissue Engineering in Musculoskeletal Medicine," Vladimir Bobic, M.D. (Royal Liverpool University Hospitals); "Development of a Retinal Prosthesis: Results of Acute Retinal Stimulation Tests in Humans," Joseph Rizzo, M.D. (Massachusetts Eye & Ear Infirmary); "Tissue Regeneration: Stem Cell Biology," Evan Snyder, M.D., Ph.D. (Children's Hospital, Boston); "A Genomics Approach to Regenerative Medicine," Craig Rosen, Ph.D. (Human Genome Sciences); "Gene Therapy: Lessons from Its First Decade," R. Michael Blaese, M.D. (Kimeragen); "Viral Vectors for Gene Therapy," James M. Wilson, M.D., Ph.D. (Institute for Human Gene Therapy, University of Pennsylvania Medical Center); "Tissue Regeneration: Stem Cell Biology," John D. Gearhart, Ph.D. (Johns Hopkins University); "Human Therapeutic Cloning: Regeneration of Somatic Cells Following Nuclear Transfer," Michael D. West, Ph.D. (Advanced Cell Technology); "Stem Cell Selection Techniques for the CNS and Other Systems," Robin Lovell-Badge, Ph.D. (National Institute for Medical Research, London); "VEGF Gene Transfer to Preserve Muscle and Nerve," Jeffrey Isner, M.D. (St. Elizabeth's Medical Center); "Regeneration Biology of Hearing," Hubert Lowenheim, M.D. (University of Tubingen, Otogene AG); "Building Brains with Stem Cells," Ron McKay, Ph.D. (LMB, NINDS, National Institutes of Health); "Tissue Regeneration: Generating Ethical Issues," Arthur Caplan, Ph.D. (Center for Bioethics, University of Pennsylvania); "The Self-Assembly Approach for Organ Reconstruction by Tissue Engineering: Realizations and Future Challenges," Francois A. Auger, M.D. (Laboratory of Experimental Organogenesis, University of Quebec); "The LIFE Initiative: Creating an Unlimited Supply of Organs for Transplantation by Tissue Engineering," Michael V. Sefton, Sc. D. (University of Toronto); "Tissue Engineering in the Genitourinary System," Anthony Atala, M.D. (Children's Hospital/Harvard Medical School); "The Relative Roles of Cells, Signals and Scaffolds in Tissue Engineering," Eugene Bell, Ph.D. (Tissue Engineering, Inc.); and "Tissue Regeneration: Cell Biology," Thomas H. Fraser, Ph.D. (Diacrin, Inc.).

Dr. Haseltine, who holds a doctorate in biophysics from Harvard, was a professor at Dana-Farber Cancer Institute, Harvard Medical School, and the Harvard School of Public Health from 1976 to 1992-3, when he founded HGS to develop genetically based products to prevent, treat and cure disease. He has a distinguished record of achievement in cancer and AIDS research and is the holder of some 50 patents, the founder of 7 medical companies, and a key developer of 20 other biotechnology businesses.

For a complete listing of conference events and participants and registration information, consult BioConferences International, Inc., is a conference and trade show management organization established in 1988 by Mary Ann Liebert, Inc., as a producer of innovative and comprehensive meetings, targeted seminars, and multi-track conventions in dynamic areas of medicine, science, technology, law, and business.

e-biomed: The Journal of Regenerative Medicine is a pioneering online refereed journal dedicated exclusively to this innovative new field of research. Papers published in e-biomed are available online to subscribers within three weeks of acceptance, and an archival print issue will be published at the end of each year. For a complimentary viewing of selected papers, visit

Mary Ann Liebert, Inc., is known for establishing the first peer-reviewed journals in the most promising areas of biomedical research, including AIDS Research and Human Retroviruses and Human Gene Therapy. The company's biotechnology publication, Genetic Engineering News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 60 publications is available at
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 23, 2000
Previous Article:Howard University Accepts $250,000 Software Endowment of TheResearchPlace, DocCentral, and Metaphrase; LGA, Inc., QuickStream, and Apelon Donation...
Next Article:Dragon's Lair Goes PlayStation 2; Digital Leisure Announces Four Classic Games Available October 26 for PS2.

Related Articles
Events calendar.
Events calendar.
Upcoming infectious disease activities.
Upcoming infectious disease activities.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters